Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.

about

Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.

Item

http://www.wikidata.org/entity/Q44412865

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Uric acid and risk of periproc ...... taneous coronary intervention.

@en

Uric acid and risk of periproc ...... taneous coronary intervention.

@nl

type

Item

label

Uric acid and risk of periproc ...... taneous coronary intervention.

@en

Uric acid and risk of periproc ...... taneous coronary intervention.

@nl

prefLabel

Uric acid and risk of periproc ...... taneous coronary intervention.

@en

Uric acid and risk of periproc ...... taneous coronary intervention.

@nl

P1476

Uric acid and risk of periproc ...... taneous coronary intervention.

@en

P2093

Alon Schaffer

http://www.w3.org/2001/XMLSchema#string

Gabriella Di Giovine

http://www.w3.org/2001/XMLSchema#string

Giuseppe De Luca

http://www.w3.org/2001/XMLSchema#string

Lucia Barbieri

http://www.w3.org/2001/XMLSchema#string

Monica Verdoia

http://www.w3.org/2001/XMLSchema#string

Novara Atherosclerosis Study Group (NAS)

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.

Recognition of the importance of embolization in atherosclerotic vascular disease.

Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis.

Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon.

Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.

Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.

Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.

Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.

Periprocedural myocardial infarction: review and classification.

P304

297-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.2495

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Marino

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24829966

http://www.w3.org/2001/XMLSchema#string